Avanos Medical, Inc. Appoints Michelle Scharfenberg as Senior Vice President & Chief Ethics and Compliance Officer
Retrieved on:
Tuesday, September 15, 2020
ALPHARETTA, Ga., Sept. 15, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michelle Scharfenberg has been named as the company's senior vice president & chief ethics and compliance officer.
Key Points:
- ALPHARETTA, Ga., Sept. 15, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michelle Scharfenberg has been named as the company's senior vice president & chief ethics and compliance officer.
- In this role, Scharfenberg will be responsible for leading the Avanos Compliance & Ethics (C&E) program, which operationalizes Avanos's commitment to ethical and legally compliant operations.
- Previously, Scharfenberg served as vice president and chief compliance officer for Cantel Medical Corporation, a leading provider of infection prevention products and services in the healthcare market.
- "I am very pleased to have Michelle join Avanos in this role," stated Joe Woody, chief executive officer.